Authors
Latest:
Market Access in UkraineOn September 16, 2014, the Ukrainian and European parliaments ratified the EU–Ukraine Association Agreement (AA), providing for harmonization of many spheres of Ukrainian legislation with EU policy.
Latest:
Customer Engagement Isnt Just About Physicians Its About Sales Reps TooManaging the pharma sales force has always been challenging. Reps are spread out geographically, often far from corporate offices, preventing them from taking part in the on-site activities and face-to-face interactions that typically foster a connection to the company.
Latest:
What AR (Augmented Reality) & Apple Vision Pro Could Mean to Health & Life Sciences Sector Navigating the New RealityEVERSANA's chief innovation discusses his experience with Apple's new device and how he thinks it might impact the life sciences industry.
Latest:
Value-Based Healthcare in the UKJill E. Sackman and Michael Kuchenreuther look at some of the pricing and reimbursement challenges in the UK and offer strategies manufacturers should consider for sustainable success.
Latest:
Europe Sees Pressure to Reduce Environmental Impact of PharmaceuticalsPressure is mounting on European legislators to introduce tighter regulations at both the European Union (EU) and national levels on the potentially harmful impact of pharmaceuticals on the environment.
Latest:
New Social Media Guidelines: What FDA Says, and What It MeansEarlier this year, FDA promised three sets of guidelines to clarify using social media for pharma marketing. Last week it delivered two of them
Latest:
EU Strengthens Transatlantic LinksThe European Union's extensive links with the US FDA and Health Canada have reached a further level of maturity, writes Peter O' Donnell.
Latest:
Bringing Fibroblasts to the Spotlight: Q&A with FibroBiologicsThese therapies may provide more stable treatments than stem cell therapies.
Latest:
Behind the Buzzwords Patient Personas are PowerfulBig, bold, blustering buzzwords are as much a part of the digital marketing landscape as the innovative, enabling technologies that spawn them. New techniques, even new spins on old techniques, demand new terminology.
Latest:
Omnicom & Publicis 5 Questions to Frame the DealSince the Omnicom-Publicis merger was announced in late July, it appears the only sources that have not commented on the joining of the superpowers are the President, the Pope, and WikiLeaks.
Latest:
Crisis Preparedness in an Always-On Digital WorldThe first 120 minutes of a crisis can determine the public’s perception of an organization. And in today’s digital world, companies are more at risk than ever to viral attacks from unexpected sources.
Latest:
Successful Social Communications The What Vs The HowGo to any communications seminar, forum, convention or workshop right now and the program will be populated with the latest and greatest trends in social communication platforms and how important these are if you want to be successful
Latest:
Assessing the Value of Retrospective Studies Real World Data Real World ApplicationsThe value of retrospective studies cannot be overstated. Retrospective studies affect many healthcare sectors, including the pharmaceutical industry and general public health
Latest:
Orphan Drug Laws A Pharmacists PerspectivePharm Exec’s sister organization CBI hosted its annual Orphan Drug Innovation Summit in Philadelphia on July 17-18. This is a topic that I have professional interest in, as well as a general curiosity.
Latest:
Challenges to the Specialty Business ModelBiopharmaceutical drug discovery companies have progressively tailored their pipelines to specialty therapeutic areas and smaller patient populations.
Latest:
Challenges to the Specialty Business ModelBiopharmaceutical drug discovery companies have progressively tailored their pipelines to specialty therapeutic areas and smaller patient populations.
Latest:
Challenges to the Specialty Business ModelBiopharmaceutical drug discovery companies have progressively tailored their pipelines to specialty therapeutic areas and smaller patient populations.
Latest:
Messaging in Healthcare: Making Sound and Fury Signify SomethingRecently, there was a bit of a dust-up over whether it was appropriate for the Secretary of Health and Human Services (HHS) to engage the National Football League (NFL) to help HHS with the process of drumming-up enrollment for health insurance exchanges. In the end, the NFL and other sports leagues decided they were not going to be involved fearing the appearance of taking political sides.
Latest:
Medicare “Wasting Billions of Dollars”, Says StudyPoorer people are being prescribed more expensive branded drugs. Is that bad? According to a new investigation it is. And it is costing the taxpayers a shovel-load of money. Furthermore, it’s unnecessary.
Latest:
Despite Growing Momentum, Repeal of Medical Device Tax Faces Significant HurdlesOn March 21, 2013, the United States Senate approved an amendment by a vote of 79 to 20 to repeal the 2.3 percent medical device excise tax.
Latest:
Value-Based Healthcare in the UKJill E. Sackman and Michael Kuchenreuther look at some of the pricing and reimbursement challenges in the UK and offer strategies manufacturers should consider for sustainable success.
Latest:
Marketing: Harnessing the Power of 'Pull'Since the early days of the internet, we’ve been busy creating websites and other digital channels.
Latest:
Is the Hatch-Waxman System Broken?While the 1984 Act has been a boon for lower-cost generics, its goal of incentivizing new drug discovery has failed.
Latest:
Is the Hatch-Waxman System Broken?While the 1984 Act has been a boon for lower-cost generics, its goal of incentivizing new drug discovery has failed.
Latest:
Remote Patient Monitoring: 2014 OutlookHistorically, pharmaceutical companies have leveraged remote patient monitoring (RPM) in a very limited way to improve data collection in clinical trials.
Latest:
Ladders Down! Successful Women Need to Help Others Come Up the Rank.“Leaning in” might be all the rage – but “hanging in” is just as important to make sure women gather momentum in the workplace. At a meeting of the Global Women in Business Advisory Council last week in Palm Springs, CA, members discussed ways to build critical mass for stronger female participation in the workplace.
Latest:
The Amazon Effect: A Data-Fueled Customer ExperienceWhat the future emergence of Amazon Pharmacy and the company’s aim to own the health experience may mean for pharma manufacturers’ engagement strategies and role in Rx delivery.
Latest:
Single Payer Issue Will Rise AgainThe future of healthcare centers on scale, population health and the value of care rather than the volume of care, according to thought leaders speaking at a leadership briefing in November in Akron, Ohio. But the political atmosphere also adds layers of complexity, they say.
Latest:
EMRs and Registries in the Era of Healthcare ReformAdvances in health information technology and new federal financial incentives are fueling rapid growth in the use of electronic medical record (EMR) systems
Latest:
Winning Pharma's Super ConferencesLike the Super Bowl, pharma companies are winning major congresses by using competitive conference techniques to generate brand buzz and corporate recognition.
